Tekamlo 150 mg / 5 mg Oral Tablet
RxNorm 1009253
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1009253 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tekamlo 150 mg / 5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Aliskiren 150 mg / amlodipine 5 mg Oral Tablet [Tekamlo]
(Atom ID: 12366214)
TMSY
Tall Man Lettering Synonym (TMSY):
Aliskiren 150 mg / amLODIPine 5 mg Oral Tablet [Tekamlo]
(Atom ID: 5081398)
PSN
Prescribable Name (PSN):
Tekamlo 150 mg / 5 mg Oral Tablet
(Atom ID: 6367428)
SY
Synonym (SY):
Tekamlo 150/5 (aliskiren / amlodipine) Oral Tablet
(Atom ID: 3298646)
TMSY
Tall Man Lettering Synonym (TMSY):
Tekamlo 150/5 (aliskiren / amLODIPine) Oral Tablet
(Atom ID: 3729848)
SY
Synonym (SY):
Tekamlo 150/5 (aliskiren hemifumarate 165.8 mg / amlodipine besylate 6.9 mg) Oral Tablet
(Atom ID: 3302853)
TMSY